![Platelet‐rich plasma with low dose oral minoxidil (1.25mg versus 2.5mg) along with trichoscopic pre‐ and post‐treatment evaluation - Jha - 2021 - Journal of Cosmetic Dermatology - Wiley Online Library Platelet‐rich plasma with low dose oral minoxidil (1.25mg versus 2.5mg) along with trichoscopic pre‐ and post‐treatment evaluation - Jha - 2021 - Journal of Cosmetic Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/da92bb0c-dd46-4602-9d24-4d725ee3e5f4/jocd14049-fig-0001-m.jpg)
Platelet‐rich plasma with low dose oral minoxidil (1.25mg versus 2.5mg) along with trichoscopic pre‐ and post‐treatment evaluation - Jha - 2021 - Journal of Cosmetic Dermatology - Wiley Online Library
Dr. Sergio Vañó on Twitter: "Treatment of male #AndrogeneticAlopecia with oral dutasteride and low dose oral minoxidil. 💊 💊 Early response after 4 months. ➡️ No adverse effects were detected! #tricoHRC #tricologiaGPJ #
![PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation”](https://i1.rgstatic.net/publication/335764203_Reply_to_Very-low-dose_oral_minoxidil_in_male_androgenetic_alopecia_A_study_with_quantitative_trichoscopic_documentation/links/5e6e6acb92851c6ba706407c/largepreview.png)
PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation”
Dr Sergio Vañó - Dermatólogo, tricólogo y cirujano capilar. Madrid - The combination of oral minoxidil + oral antiandrogenic drugs (eg: dutasteride and/or spironolactone) may be useful in some female patients with #
![Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients - Journal of the American Academy of Dermatology Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a83038a8-6b81-46dc-a8db-20e52cf217cb/gr1_lrg.jpg)
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients - Journal of the American Academy of Dermatology
![Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation - Journal of the American Academy of Dermatology Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1a0f6891-374e-4102-81d3-aa40c5b00e96/gr1_lrg.jpg)
Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation - Journal of the American Academy of Dermatology
![Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” - Journal of the American Academy of Dermatology Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c8586823-e118-4464-a9b3-ab144819fe57/gr1_lrg.jpg)